메뉴 건너뛰기




Volumn 25, Issue 5, 2004, Pages 227-236

DM27, an enaminone, modifies the in vitro transport of antiviral therapeutic agents

Author keywords

Anti HIV; Antiviral drugs; Bioavailability; DM27; Enaminones

Indexed keywords

3 [N (4 CHLOROPHENYL)AMINO] 5 METHYL 2 CYCLOHEXENONE; ACICLOVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CARBON 14; DM 27; ENAMINONE; GLYCOPROTEIN P INHIBITOR; MANNITOL; PACLITAXEL; PROPRANOLOL; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; THIAZOLE DERIVATIVE; TRITIUM; UNCLASSIFIED DRUG; ZIDOVUDINE;

EID: 4043062217     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdd.404     Document Type: Article
Times cited : (38)

References (33)
  • 1
    • 0032847425 scopus 로고    scopus 로고
    • Oral absorption of the HIV protease inhibitors: A current update
    • Williams GC, Sinko PJ. Oral absorption of the HIV protease inhibitors: a current update. Adv Drug Deliv Rev 1999; 39: 211-238.
    • (1999) Adv. Drug Deliv. Rev. , vol.39 , pp. 211-238
    • Williams, G.C.1    Sinko, P.J.2
  • 2
    • 0032518290 scopus 로고    scopus 로고
    • The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
    • Kim RB, Fromm MF, Wandel C, et al. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest 1998; 101: 289-294.
    • (1998) J. Clin. Invest. , vol.101 , pp. 289-294
    • Kim, R.B.1    Fromm, M.F.2    Wandel, C.3
  • 3
    • 0032906888 scopus 로고    scopus 로고
    • Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in mdr1a P-glycoprotein
    • Kwei GY, Alvaro RF, Chen Q, et al. Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in mdr1a P-glycoprotein. Drug Metab Dispos 1999; 27: 581-587.
    • (1999) Drug Metab. Dispos. , vol.27 , pp. 581-587
    • Kwei, G.Y.1    Alvaro, R.F.2    Chen, Q.3
  • 4
    • 12644278301 scopus 로고    scopus 로고
    • Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
    • Sparreboom A, Asperen JV, Mayer U, et al. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci USA 1997; 94: 2031-2035.
    • (1997) Proc. Natl. Acad. Sci. USA , vol.94 , pp. 2031-2035
    • Sparreboom, A.1    Asperen, J.V.2    Mayer, U.3
  • 5
    • 0033795486 scopus 로고    scopus 로고
    • Commentary: Potential role of P-glycoprotein in affecting hepatic metabolism of drugs
    • Chiou WL, Chung SM, Wu TC. Commentary: Potential role of P-glycoprotein in affecting hepatic metabolism of drugs. Pharm Res 2000; 17: 901-903.
    • (2000) Pharm. Res. , vol.17 , pp. 901-903
    • Chiou, W.L.1    Chung, S.M.2    Wu, T.C.3
  • 6
    • 0034762283 scopus 로고    scopus 로고
    • Influence of multidrug resistance (MDR) proteins at the blood-brain barrier on the transport and brain distribution of enaminone anticonvulsants
    • Cox DS, Scott KR, Gao H, Raje S, Eddington ND. Influence of multidrug resistance (MDR) proteins at the blood-brain barrier on the transport and brain distribution of enaminone anticonvulsants. J Pharm Sci 2001; 90: 1540-1552.
    • (2001) J. Pharm. Sci. , vol.90 , pp. 1540-1552
    • Cox, D.S.1    Scott, K.R.2    Gao, H.3    Raje, S.4    Eddington, N.D.5
  • 8
    • 0034880291 scopus 로고    scopus 로고
    • Enhancing the permeation of marker compounds and enaminone anticonvulsants across Caco-2 monolayers by modulating tight junctions using zonula occludens toxin
    • Cox DS, Scott KR, Gao H, Raje S, Eddington ND. Enhancing the permeation of marker compounds and enaminone anticonvulsants across Caco-2 monolayers by modulating tight junctions using zonula occludens toxin. Eur J Pharm Biopharm 2001; 52: 145-150.
    • (2001) Eur. J. Pharm. Biopharm. , vol.52 , pp. 145-150
    • Cox, D.S.1    Scott, K.R.2    Gao, H.3    Raje, S.4    Eddington, N.D.5
  • 9
    • 0027182857 scopus 로고
    • Synthesis and anticonvulsant activity of enaminones. 2. Further structure-activity correlations
    • Scott KR, Edafiogho IO, Richardson EL, et al. Synthesis and anticonvulsant activity of enaminones. 2. Further structure-activity correlations. J Med Chem 1993; 36: 1947-1955.
    • (1993) J. Med. Chem. , vol.36 , pp. 1947-1955
    • Scott, K.R.1    Edafiogho, I.O.2    Richardson, E.L.3
  • 10
    • 0026321138 scopus 로고
    • Cell cultures as models for drug absorption across the intestinal mucosa
    • Artursson P. Cell cultures as models for drug absorption across the intestinal mucosa. Crit Rev Ther Drug Carr Syst 1991; 8: 305-330.
    • (1991) Crit. Rev. Ther. Drug Carr. Syst. , vol.8 , pp. 305-330
    • Artursson, P.1
  • 11
    • 0024593744 scopus 로고
    • Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability
    • Hidalgo IJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989; 96: 736-749.
    • (1989) Gastroenterology , vol.96 , pp. 736-749
    • Hidalgo, I.J.1    Raub, T.J.2    Borchardt, R.T.3
  • 12
    • 4043069675 scopus 로고    scopus 로고
    • In vitro and in vivo functional evaluation of the enaminones as a novel series of P-glycoprotein modulators for different therapeutic agents
    • October 26-30, 2003, Salt Lake City, Utah. (abstr)
    • Salama NN, Scott KR, Eddington ND. In vitro and in vivo functional evaluation of the enaminones as a novel series of P-glycoprotein modulators for different therapeutic agents. In 18th Annual Meeting and Exposition of the American Association of Pharmaceutical Scientists, October 26-30, 2003, Salt Lake City, Utah. 2003; (abstr).
    • (2003) 18th Annual Meeting and Exposition of the American Association of Pharmaceutical Scientists
    • Salama, N.N.1    Scott, K.R.2    Eddington, N.D.3
  • 13
    • 1542346470 scopus 로고    scopus 로고
    • The influence of enaminones on the transport and oral bioavailability of P-gp substrate therapeutic agents
    • Salama NN, Scott KR, Eddington ND. The influence of enaminones on the transport and oral bioavailability of P-gp substrate therapeutic agents. Int J Pharm 2004; 273: 135-147.
    • (2004) Int. J. Pharm. , vol.273 , pp. 135-147
    • Salama, N.N.1    Scott, K.R.2    Eddington, N.D.3
  • 14
    • 0023268502 scopus 로고
    • The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial
    • Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 1987; 317: 185-191.
    • (1987) N. Engl. J. Med. , vol.317 , pp. 185-191
    • Fischl, M.A.1    Richman, D.D.2    Grieco, M.H.3
  • 15
    • 0030895312 scopus 로고    scopus 로고
    • Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations
    • Barry M, Gibbons S, Back D, Mulcahy F. Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations. Clin Pharmacokinet 1997; 32: 194-209.
    • (1997) Clin. Pharmacokinet. , vol.32 , pp. 194-209
    • Barry, M.1    Gibbons, S.2    Back, D.3    Mulcahy, F.4
  • 16
    • 0037204543 scopus 로고    scopus 로고
    • Progress in understanding the structure-activity relationships of P-glycoprotein
    • Stouch TR, Gudmundsson O. Progress in understanding the structure-activity relationships of P-glycoprotein. Adv Drug Deliv Rev 2002; 54: 315-328.
    • (2002) Adv. Drug Deliv. Rev. , vol.54 , pp. 315-328
    • Stouch, T.R.1    Gudmundsson, O.2
  • 17
    • 0041402720 scopus 로고    scopus 로고
    • Efflux ratios cannot assess P-glycoprotein-mediated attenuation of absorptive transport: Asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers
    • Troutman MD, Thakker DR. Efflux ratios cannot assess P-glycoprotein-mediated attenuation of absorptive transport: Asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers. Pharm Res 2003; 20: 1200-1209.
    • (2003) Pharm. Res. , vol.20 , pp. 1200-1209
    • Troutman, M.D.1    Thakker, D.R.2
  • 18
    • 0042905800 scopus 로고    scopus 로고
    • Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in intestinal epithelium
    • Troutman MD, Thakker DR. Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in intestinal epithelium. Pharm Res 2003; 20: 1210-1223.
    • (2003) Pharm. Res. , vol.20 , pp. 1210-1223
    • Troutman, M.D.1    Thakker, D.R.2
  • 19
    • 0031941789 scopus 로고    scopus 로고
    • Taxol transport by human intestinal epithelial Caco-2 cells
    • Walle UK, Walle T. Taxol transport by human intestinal epithelial Caco-2 cells. Drug Metab Dispos 1998; 26: 343-346.
    • (1998) Drug Metab. Dispos. , vol.26 , pp. 343-346
    • Walle, U.K.1    Walle, T.2
  • 20
    • 0037261361 scopus 로고    scopus 로고
    • Enhanced oral bioavailability of paclitaxel by coadministration of the P-glcoprotein inhibitor KR30031
    • Woo JS, Lee CH, Shim CK, Hwang SJ. Enhanced oral bioavailability of paclitaxel by coadministration of the P-glcoprotein inhibitor KR30031. Pharm Res 2003; 20: 24-30.
    • (2003) Pharm. Res. , vol.20 , pp. 24-30
    • Woo, J.S.1    Lee, C.H.2    Shim, C.K.3    Hwang, S.J.4
  • 21
    • 0032883658 scopus 로고    scopus 로고
    • Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers
    • Batrakova EV, Li S, Miller DW, Kabanov AV. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Pharm Res 1999; 16: 1366-1372.
    • (1999) Pharm. Res. , vol.16 , pp. 1366-1372
    • Batrakova, E.V.1    Li, S.2    Miller, D.W.3    Kabanov, A.V.4
  • 22
    • 0027524642 scopus 로고
    • In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative
    • Hyafil F, Vergely C, Du Vignaud P, Grand-Perret T. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res 1993; 53: 4595-4602.
    • (1993) Cancer Res. , vol.53 , pp. 4595-4602
    • Hyafil, F.1    Vergely, C.2    Du Vignaud, P.3    Grand-Perret, T.4
  • 23
    • 0031962285 scopus 로고    scopus 로고
    • How does P-glycoprotein recognize its substrates?
    • Seelig A. How does P-glycoprotein recognize its substrates? Int J Clin Pharmacol Ther 1998; 36: 50-54.
    • (1998) Int. J. Clin. Pharmacol. Ther. , vol.36 , pp. 50-54
    • Seelig, A.1
  • 26
    • 0032955402 scopus 로고    scopus 로고
    • Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection
    • Barry M, Mulcahy F, Merry C, Gibbons S, Back D. Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection. Clin Pharmacokinet 1999; 36: 289-304.
    • (1999) Clin. Pharmacokinet. , vol.36 , pp. 289-304
    • Barry, M.1    Mulcahy, F.2    Merry, C.3    Gibbons, S.4    Back, D.5
  • 27
    • 0030428226 scopus 로고    scopus 로고
    • In vitro techniques for studying drug metabolism
    • Guengerich FP. In vitro techniques for studying drug metabolism. J Pharmacokinet Biopharm 1996; 24: 521-533.
    • (1996) J. Pharmacokinet. Biopharm. , vol.24 , pp. 521-533
    • Guengerich, F.P.1
  • 28
    • 0034940754 scopus 로고    scopus 로고
    • The role of P-glycoprotein in limiting intestinal regional absorption of digoxin in rats
    • Sababi M, Borga O, Hultkvist-Bengtsson U. The role of P-glycoprotein in limiting intestinal regional absorption of digoxin in rats. Eur J Pharm Sci 2001; 14: 21-27.
    • (2001) Eur. J. Pharm. Sci. , vol.14 , pp. 21-27
    • Sababi, M.1    Borga, O.2    Hultkvist-Bengtsson, U.3
  • 29
    • 0343416856 scopus 로고    scopus 로고
    • Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery
    • Hebert MF. Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery. Adv Drug Deliv Rev 1997; 27: 201-214.
    • (1997) Adv. Drug Deliv. Rev. , vol.27 , pp. 201-214
    • Hebert, M.F.1
  • 30
    • 0032907322 scopus 로고    scopus 로고
    • Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein
    • Kim RB, Wandel C, Leake B, et al. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. Pharmacol Res 1999; 16: 408-414.
    • (1999) Pharmacol. Res. , vol.16 , pp. 408-414
    • Kim, R.B.1    Wandel, C.2    Leake, B.3
  • 31
    • 0036488144 scopus 로고    scopus 로고
    • The distribution of the anti-HIV drug, 2′3′-dideoxycytidine (ddc), across the blood-brain and blood-cerebrospinal fluid barriers and the influence of organic anion transport inhibitors
    • Gibbs JE, Thomas SA. The distribution of the anti-HIV drug, 2′3′-dideoxycytidine (ddc), across the blood-brain and blood-cerebrospinal fluid barriers and the influence of organic anion transport inhibitors. J Neurochem 2002; 80: 392-404.
    • (2002) J. Neurochem. , vol.80 , pp. 392-404
    • Gibbs, J.E.1    Thomas, S.A.2
  • 32
    • 0032728058 scopus 로고    scopus 로고
    • Role of P-glycoprotein in the renal transport of dideoxyriucleoside analog drugs
    • Leung S, Bendayan R. Role of P-glycoprotein in the renal transport of dideoxyriucleoside analog drugs. Can J Physiol Pharmacol 1999; 77: 625-630.
    • (1999) Can. J. Physiol. Pharmacol. , vol.77 , pp. 625-630
    • Leung, S.1    Bendayan, R.2
  • 33
    • 0028935166 scopus 로고
    • Modulators of multidrug resistance. Preclinical studies
    • Ford JM. Modulators of multidrug resistance. Preclinical studies. Hemato Oncol Clin North Am 1995; 9: 337-361.
    • (1995) Hemato. Oncol. Clin. North Am. , vol.9 , pp. 337-361
    • Ford, J.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.